tiprankstipranks
Yara International (YARIY)
OTHER OTC:YARIY

Yara International (YARIY) AI Stock Analysis

Compare
123 Followers

Top Page

YARIY

Yara International

(OTC:YARIY)

Select Model
Select Model
Select Model
Outperform 71 (OpenAI - 5.2)
Rating:71Outperform
Price Target:
$30.00
▲(66.94% Upside)
Action:UpgradedDate:02/18/26
The score is driven primarily by improving financial performance in 2025 (profit and free cash flow rebound with manageable leverage) and strong technical momentum (price above key moving averages with positive MACD). This is tempered by cyclical earnings/cash-flow variability, a modest valuation/income profile (P/E ~16.5 and ~1% yield), and earnings-call risks around regulatory uncertainty, near-term demand timing, and project/working-capital pressures.
Positive Factors
Global crop-nutrition scale & logistics network
Yara’s global manufacturing, trading and distribution footprint and breadth of nitrogen products create durable commercial advantages: broad customer reach, the ability to arbitrage regional input/price spreads and to capture logistics-enabled margins across cycles, improving resilience over months.
Negative Factors
Earnings and cash-flow cyclicality
Yara’s earnings and cash generation swing materially with commodity cycles and seasonal farming demand. That persistent volatility weakens predictability for returns, makes capital allocation timing harder, and raises the risk that good cash years won’t persist through downturns.
Read all positive and negative factors
Positive Factors
Negative Factors
Global crop-nutrition scale & logistics network
Yara’s global manufacturing, trading and distribution footprint and breadth of nitrogen products create durable commercial advantages: broad customer reach, the ability to arbitrage regional input/price spreads and to capture logistics-enabled margins across cycles, improving resilience over months.
Read all positive factors

Yara International (YARIY) vs. SPDR S&P 500 ETF (SPY)

Yara International Business Overview & Revenue Model

Company Description
Yara International ASA is a global leader in crop nutrition and a key player in the agricultural sector. Founded in Norway in 1905, the company specializes in the production and distribution of nitrogen-based fertilizers, as well as providing sust...
How the Company Makes Money
Yara primarily makes money by manufacturing, marketing, and selling crop nutrition products and other nitrogen-based solutions. Its largest revenue stream comes from sales of mineral fertilizers—especially nitrogen fertilizers (e.g., nitrate-based...

Yara International Earnings Call Summary

Earnings Call Date:Feb 11, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Apr 24, 2026
Earnings Call Sentiment Neutral
The call balanced clear commercial and operational strengths (strong Q4 Europe demand, production uptime, tight global nitrogen market, disciplined capital allocation and carbon position) against notable near‑term and medium‑term risks (CBAM political uncertainty, Q1 seasonality/stocking effects, NPK premium pressure, working capital build, and cost/timing risk on a major U.S. decarbonization project). Management’s tone was cautiously constructive: confident on market fundamentals and execution but circumspect about regulatory and project cost risk.
Positive Updates
Strong Q4 Europe Demand and Price Momentum
Yara reported strong Q4 sales in Europe driven largely by customer and importer positioning ahead of CBAM (effective Jan 1), which contributed to price increases across products in Q4.
Negative Updates
CBAM Political Uncertainty
While CBAM is in force (impacting Q4 pricing), a proposed legislative amendment (Paragraph 27a) to allow temporary suspension has created political uncertainty; outcome requires European Parliament approval and remains unpredictable.
Read all updates
Q4-2025 Updates
Negative
Strong Q4 Europe Demand and Price Momentum
Yara reported strong Q4 sales in Europe driven largely by customer and importer positioning ahead of CBAM (effective Jan 1), which contributed to price increases across products in Q4.
Read all positive updates
Company Guidance
Management guided that deliveries were about 7% ahead at end‑December versus last year with roughly half the seasonal demand still to be bought (the EU imported ~2.2 Mt of urea in Q1 last year), noting short‑term market drivers such as U.S. Gulf urea at ~$500/t, India’s 1.5 Mt tender and Chinese exports having risen ~5 Mt in 2025 (consultant baselines cited ~6 Mt for 2026). They said 2026 maintenance CapEx is ~USD 200m higher versus 2025 and sits in the upper part of their maintenance range (USD 700–850m/year), with total CapEx run‑rate around USD 1.2bn in the coming years; the Air Products project remains within previously stated ranges (NOK 8–9bn) but no new update was given. Working capital is seasonal (build into spring then release) and Q4 price strength lifted receivables and caused a modest inventory build; NPK premium pressure hit roughly $20–30m in Q4. Yara reported holding about 6 million ETS allowances (covering needs through ~2029), reiterated a 50% cash dividend policy, and confirmed there are no special turnaround plans materially different to prior years.

Yara International Financial Statement Overview

Summary
Financials show a clear 2025 rebound (revenue up ~3.9% YoY, net income up to ~$1.37B from near break-even in 2024) and stronger cash generation (2025 OCF ~$1.89B; FCF ~$0.96B). Balance sheet leverage is moderate and stable (debt ~$4.0–$4.3B; sizable equity), but earnings and cash flow remain meaningfully cyclical, limiting confidence in through-cycle stability.
Income Statement
66
Positive
Balance Sheet
72
Positive
Cash Flow
69
Positive
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue15.62B13.81B15.43B23.90B16.62B
Gross Profit4.42B3.68B3.34B6.55B4.48B
EBITDA3.12B1.41B1.47B4.83B2.58B
Net Income1.37B14.00M48.00M2.78B449.00M
Balance Sheet
Total Assets17.14B14.99B16.03B17.98B17.27B
Cash, Cash Equivalents and Short-Term Investments913.00M317.00M447.00M908.00M350.00M
Total Debt4.18B4.05B4.23B4.22B4.33B
Total Liabilities8.39B7.99B8.46B9.38B10.15B
Stockholders Equity8.72B6.99B7.55B8.59B7.10B
Cash Flow
Free Cash Flow956.00M248.00M1.15B1.47B597.00M
Operating Cash Flow1.89B1.29B2.29B2.39B1.41B
Investing Cash Flow-906.00M-1.08B-1.20B-509.00M-874.00M
Financing Cash Flow-392.00M-401.00M-1.52B-1.23B-1.50B

Yara International Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price17.97
Price Trends
50DMA
24.18
Positive
100DMA
21.61
Positive
200DMA
20.13
Positive
Market Momentum
MACD
1.04
Positive
RSI
45.59
Neutral
STOCH
40.61
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For YARIY, the sentiment is Neutral. The current price of 17.97 is below the 20-day moving average (MA) of 26.47, below the 50-day MA of 24.18, and below the 200-day MA of 20.13, indicating a neutral trend. The MACD of 1.04 indicates Positive momentum. The RSI at 45.59 is Neutral, neither overbought nor oversold. The STOCH value of 40.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for YARIY.

Yara International Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
$18.47B8.6229.95%2.56%12.59%31.40%
71
Outperform
$12.88B15.1916.79%1.16%7.55%34.28%
68
Neutral
$7.65B14.149.96%3.70%3.82%239.39%
62
Neutral
$3.81B-6.71-27.23%4.52%-3.93%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
59
Neutral
$6.54B32.613.77%3.36%1.77%-8.72%
49
Neutral
$1.78B-0.78-61.24%16.68%-13.42%-136.59%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
YARIY
Yara International
26.80
11.61
76.41%
CF
Cf Industries Holdings
126.92
53.60
73.09%
FMC
FMC
14.83
-24.56
-62.35%
MOS
Mosaic Co
25.20
-1.17
-4.43%
SMG
Scotts Miracle-Gro Company
66.84
12.54
23.10%
ICL
Icl
5.15
-0.42
-7.46%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026